| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucosamine-6-phosphate deaminase activity | 2.79e-05 | 2 | 106 | 2 | GO:0004342 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 6.30e-05 | 187 | 106 | 7 | GO:0016922 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 2.08e-04 | 55 | 106 | 4 | GO:0042974 | |
| GeneOntologyBiologicalProcess | glucosamine catabolic process | 2.67e-05 | 2 | 107 | 2 | GO:0006043 | |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 3.65e-05 | 119 | 107 | 6 | GO:0006892 | |
| Domain | Pkinase_C | 1.67e-06 | 37 | 102 | 5 | IPR017892 | |
| Domain | Pkinase_C | 3.19e-06 | 42 | 102 | 5 | PF00433 | |
| Domain | AGC-kinase_C | 1.35e-05 | 56 | 102 | 5 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 1.35e-05 | 56 | 102 | 5 | PS51285 | |
| Domain | S_TK_X | 1.35e-05 | 56 | 102 | 5 | SM00133 | |
| Domain | Glucosamine6P_isomerase_CS | 2.95e-05 | 2 | 102 | 2 | IPR018321 | |
| Domain | Glucosamine6P_isomerase | 2.95e-05 | 2 | 102 | 2 | IPR004547 | |
| Domain | GLC_GALNAC_ISOMERASE | 2.95e-05 | 2 | 102 | 2 | PS01161 | |
| Domain | Amphiphysin | 8.83e-05 | 3 | 102 | 2 | IPR003005 | |
| Domain | PRAME_family | 1.44e-04 | 19 | 102 | 3 | IPR026271 | |
| Domain | Glc/Gal-6P_isomerase | 1.76e-04 | 4 | 102 | 2 | IPR006148 | |
| Domain | Glucosamine_iso | 1.76e-04 | 4 | 102 | 2 | PF01182 | |
| Domain | - | 2.92e-04 | 5 | 102 | 2 | 1.10.1200.10 | |
| Domain | PP-binding | 2.92e-04 | 5 | 102 | 2 | PF00550 | |
| Domain | ACP_DOMAIN | 2.92e-04 | 5 | 102 | 2 | PS50075 | |
| Domain | Methyltransf_12 | 4.37e-04 | 6 | 102 | 2 | IPR013217 | |
| Domain | Methyltransf_12 | 4.37e-04 | 6 | 102 | 2 | PF08242 | |
| Domain | Ribosomal_S6_kinase_II | 4.37e-04 | 6 | 102 | 2 | IPR016239 | |
| Domain | PP-bd_ACP | 4.37e-04 | 6 | 102 | 2 | IPR009081 | |
| Pubmed | 1.17e-06 | 172 | 108 | 7 | 23184937 | ||
| Pubmed | GNPDA1 TTC14 RNF213 BIRC6 SHANK3 CCDC85A TBC1D9 FARP2 PTCD1 TTC21B | 3.35e-06 | 493 | 108 | 10 | 15368895 | |
| Pubmed | 7.46e-06 | 320 | 108 | 8 | 28685749 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 19923902 | ||
| Pubmed | Two mammalian glucosamine-6-phosphate deaminases: a structural and genetic study. | 9.55e-06 | 2 | 108 | 2 | 12965206 | |
| Pubmed | NDR functions as a physiological YAP1 kinase in the intestinal epithelium. | 9.55e-06 | 2 | 108 | 2 | 25601544 | |
| Pubmed | The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway. | 9.55e-06 | 2 | 108 | 2 | 21502810 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23487784 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12616532 | ||
| Pubmed | Birth and rapid subcellular adaptation of a hominoid-specific CDC14 protein. | 9.55e-06 | 2 | 108 | 2 | 18547142 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22419116 | ||
| Pubmed | Reduction of hepatitis C virus NS5A phosphorylation through its interaction with amphiphysin II. | 9.55e-06 | 2 | 108 | 2 | 16139795 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12095943 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12697818 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 37462338 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12771149 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15556626 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15037617 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | ATP6V0A1 GNPDA1 ANKFY1 SPTBN1 SRC ADCY1 FASN OSBPL1A GSTCD SERPING1 CCDC180 UTRN MNDA | 1.66e-05 | 1016 | 108 | 13 | 19056867 |
| Pubmed | 2.36e-05 | 272 | 108 | 7 | 31010829 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ATP6V0A1 ANKFY1 RPS6KA4 RPS6KA1 SRC TTC14 STK38 CCNA2 AGO4 EIF3B STK38L UTRN | 2.68e-05 | 910 | 108 | 12 | 36736316 |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 26060254 | ||
| Pubmed | Early-onset aging and defective DNA damage response in Cdc14b-deficient mice. | 2.86e-05 | 3 | 108 | 2 | 21262768 | |
| Pubmed | Human NDR kinases control G(1)/S cell cycle transition by directly regulating p21 stability. | 2.86e-05 | 3 | 108 | 2 | 21262772 | |
| Pubmed | SIRT2 regulates tumour hypoxia response by promoting HIF-1α hydroxylation. | 2.86e-05 | 3 | 108 | 2 | 24681946 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 23897809 | ||
| Pubmed | Cdc14b regulates mammalian RNA polymerase II and represses cell cycle transcription. | 2.86e-05 | 3 | 108 | 2 | 22355704 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 25542144 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 26951539 | ||
| Pubmed | Differential activation of recombinant human acetyl-CoA carboxylases 1 and 2 by citrate. | 2.86e-05 | 3 | 108 | 2 | 18455495 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 21376300 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 22011838 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 17507630 | ||
| Pubmed | CDC14B acts through FZR1 (CDH1) to prevent meiotic maturation of mouse oocytes. | 2.86e-05 | 3 | 108 | 2 | 19129509 | |
| Pubmed | Cdc14A and Cdc14B Redundantly Regulate DNA Double-Strand Break Repair. | 2.86e-05 | 3 | 108 | 2 | 26283732 | |
| Pubmed | HIV-1 incorporates and proteolytically processes human NDR1 and NDR2 serine-threonine kinases. | 2.86e-05 | 3 | 108 | 2 | 15582665 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 2.90e-05 | 281 | 108 | 7 | 28706196 | |
| Pubmed | 3.19e-05 | 20 | 108 | 3 | 26694250 | ||
| Pubmed | 4.30e-05 | 22 | 108 | 3 | 31729367 | ||
| Pubmed | 5.03e-05 | 418 | 108 | 8 | 34709266 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 19062280 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 18802114 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 21335603 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 11032808 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 36577884 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 9701558 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 32341029 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 37212571 | ||
| Pubmed | CDC14A phosphatase is essential for hearing and male fertility in mouse and human. | 5.71e-05 | 4 | 108 | 2 | 29293958 | |
| Pubmed | Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein. | 5.71e-05 | 4 | 108 | 2 | 15197186 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 6.33e-05 | 558 | 108 | 9 | 27591049 | |
| Pubmed | 6.37e-05 | 25 | 108 | 3 | 37451217 | ||
| Pubmed | 6.51e-05 | 69 | 108 | 4 | 16541075 | ||
| Pubmed | 9.02e-05 | 28 | 108 | 3 | 25089626 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 19739075 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 15601848 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 11013076 | ||
| Pubmed | Human Mob proteins regulate the NDR1 and NDR2 serine-threonine kinases. | 9.50e-05 | 5 | 108 | 2 | 15067004 | |
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 26303530 | ||
| Pubmed | Acetyl-CoA carboxylase 1 is a suppressor of the adipocyte thermogenic program. | 9.50e-05 | 5 | 108 | 2 | 37163372 | |
| Pubmed | Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity. | 9.50e-05 | 5 | 108 | 2 | 16606610 | |
| Pubmed | Ndr kinases regulate retinal interneuron proliferation and homeostasis. | 9.50e-05 | 5 | 108 | 2 | 30135513 | |
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 29483509 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 36657504 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 26887390 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 12072427 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 15784253 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 11826110 | ||
| Pubmed | DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. | 1.42e-04 | 6 | 108 | 2 | 22581261 | |
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 12630920 | ||
| Pubmed | Loss of NDR1/2 kinases impairs endomembrane trafficking and autophagy leading to neurodegeneration. | 1.42e-04 | 6 | 108 | 2 | 36446521 | |
| Pubmed | Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. | 1.42e-04 | 6 | 108 | 2 | 8688081 | |
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 11175347 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.44e-04 | 363 | 108 | 7 | 14691545 | |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 1.53e-04 | 256 | 108 | 6 | 32698014 | |
| Pubmed | Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation. | 1.62e-04 | 34 | 108 | 3 | 30726710 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GNPDA1 ANKFY1 COPB1 RPS6KA1 SPTBN1 TPRKB QRICH1 BIRC6 FASN GNPDA2 BYSL EIF3B EPB41L1 VCPIP1 | 1.68e-04 | 1455 | 108 | 14 | 22863883 |
| Pubmed | 1.77e-04 | 35 | 108 | 3 | 19389355 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 1.81e-04 | 377 | 108 | 7 | 38117590 | |
| Pubmed | Specific interactions of neuronal focal adhesion kinase isoforms with Src kinases and amphiphysin. | 1.99e-04 | 7 | 108 | 2 | 12558988 | |
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 28775078 | ||
| Pubmed | Granzyme A produces bioactive IL-1β through a nonapoptotic inflammasome-independent pathway. | 1.99e-04 | 7 | 108 | 2 | 25437548 | |
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 15602573 | ||
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 10922375 | ||
| Pubmed | Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes. | 2.64e-04 | 8 | 108 | 2 | 12145209 | |
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 24302728 | ||
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 30319350 | ||
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 27015965 | ||
| Pubmed | The Lyn kinase C-lobe mediates Golgi export of Lyn through conformation-dependent ACSL3 association. | 2.64e-04 | 8 | 108 | 2 | 20605918 | |
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 15834155 | ||
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 19281832 | ||
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 9829964 | ||
| Pubmed | Quantitative study of the interactome of PKCζ involved in the EGF-induced tumor cell chemotaxis. | 2.82e-04 | 184 | 108 | 5 | 23402259 | |
| Pubmed | Genome-wide association study identifies five loci associated with lung function. | 3.39e-04 | 9 | 108 | 2 | 20010834 | |
| Pubmed | 3.39e-04 | 9 | 108 | 2 | 20362473 | ||
| Pubmed | Non-erythroid beta spectrin interacting proteins and their effects on spectrin tetramerization. | 3.39e-04 | 9 | 108 | 2 | 21866423 | |
| Pubmed | 3.54e-04 | 421 | 108 | 7 | 36976175 | ||
| Pubmed | Systematic identification of molecular links between core and candidate genes in breast cancer. | 3.59e-04 | 194 | 108 | 5 | 25640309 | |
| Pubmed | 3.72e-04 | 708 | 108 | 9 | 39231216 | ||
| Pubmed | Sex-hormone-driven innate antibodies protect females and infants against EPEC infection. | 4.23e-04 | 10 | 108 | 2 | 30250184 | |
| GeneFamily | PRAME family | 9.73e-05 | 24 | 68 | 3 | 686 | |
| GeneFamily | Mitogen-activated protein kinase-activated protein kinases | 7.50e-04 | 11 | 68 | 2 | 1156 | |
| GeneFamily | N-BAR domain containing | 8.98e-04 | 12 | 68 | 2 | 1289 | |
| GeneFamily | Ankyrin repeat domain containing | 2.16e-03 | 242 | 68 | 5 | 403 | |
| Coexpression | NOTCH_DN.V1_UP | 1.03e-05 | 186 | 105 | 7 | M2789 | |
| Coexpression | GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP | 1.49e-05 | 197 | 105 | 7 | M3136 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.80e-07 | 171 | 106 | 7 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.45e-07 | 179 | 106 | 7 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-06 | 169 | 106 | 6 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 169 | 106 | 6 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.75e-06 | 187 | 106 | 6 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-06 | 189 | 106 | 6 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-06 | 192 | 106 | 6 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-06 | 194 | 106 | 6 | a429d22c8c9d0fd3bfa9f877a6364cecad68db30 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.52e-06 | 196 | 106 | 6 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.97e-06 | 198 | 106 | 6 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.44e-06 | 200 | 106 | 6 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-05 | 146 | 106 | 5 | 5b2608b56204dda9a773988f42ff00a9fa743a39 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-05 | 151 | 106 | 5 | 3744e4ed87703a97002e001afd16490d525a5128 | |
| ToppCell | FLU-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 3.93e-05 | 159 | 106 | 5 | 97c8e16a7ac10ebba96daee97f9fb1d4a404f23b | |
| ToppCell | FLU-Healthy-1|FLU / Virus stimulation, Condition and Cluster | 3.93e-05 | 159 | 106 | 5 | fe2a9f79b058e89214256e736f6e266830cdfa28 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-2|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 4.05e-05 | 160 | 106 | 5 | d288b0a315f6adc0be4bdc89fa67bf93679a743f | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 4.97e-05 | 167 | 106 | 5 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.09e-05 | 180 | 106 | 5 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.27e-05 | 181 | 106 | 5 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 183 | 106 | 5 | ffb1bbbccb34d1a7e99872611f497450039d5019 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.86e-05 | 184 | 106 | 5 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.86e-05 | 184 | 106 | 5 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.06e-05 | 185 | 106 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.27e-05 | 186 | 106 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.14e-05 | 190 | 106 | 5 | e1c02fe6fa43a36381cb9f02569fa9b1c5f5efdc | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 9.14e-05 | 190 | 106 | 5 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-05 | 190 | 106 | 5 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.14e-05 | 190 | 106 | 5 | 6de15ec88426fbf52acb0a8371f82cf03b6a6237 | |
| ToppCell | control-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.37e-05 | 191 | 106 | 5 | afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.37e-05 | 191 | 106 | 5 | 81f77bf497b8e0ae0affe7d5f4f00446547229f6 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 9.60e-05 | 192 | 106 | 5 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | Control-Myeloid-cMonocyte|Control / Disease state, Lineage and Cell class | 9.60e-05 | 192 | 106 | 5 | ad04c9c4bdebf94615cee1904ca48197e62c923b | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.84e-05 | 193 | 106 | 5 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 9.84e-05 | 193 | 106 | 5 | e790ab76c12f74a13936c231076f1e397283efb3 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 9.84e-05 | 193 | 106 | 5 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | Control-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 1.01e-04 | 194 | 106 | 5 | f852f5258617a66a4fbd56d64c7b47272e7b8b60 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 1.01e-04 | 194 | 106 | 5 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.01e-04 | 194 | 106 | 5 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Mild/Remission-B_activate-7|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.01e-04 | 194 | 106 | 5 | 01c97543972159a9468272da06e7e611e2c21fae | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 1.01e-04 | 194 | 106 | 5 | 7773501e076d470158dbc1d7f10c67152b326eb7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 194 | 106 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 1.01e-04 | 194 | 106 | 5 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.03e-04 | 195 | 106 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-04 | 195 | 106 | 5 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 1.03e-04 | 195 | 106 | 5 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.03e-04 | 195 | 106 | 5 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.03e-04 | 195 | 106 | 5 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.03e-04 | 195 | 106 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-04 | 195 | 106 | 5 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-04 | 195 | 106 | 5 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.03e-04 | 195 | 106 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.03e-04 | 195 | 106 | 5 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 1.06e-04 | 196 | 106 | 5 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 196 | 106 | 5 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | CV-Moderate-1|Moderate / Virus stimulation, Condition and Cluster | 1.06e-04 | 196 | 106 | 5 | b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 196 | 106 | 5 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 196 | 106 | 5 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 196 | 106 | 5 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.06e-04 | 196 | 106 | 5 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 196 | 106 | 5 | 629236f95c838a473b5964a49b7c1b7ad863ea12 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 196 | 106 | 5 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.08e-04 | 197 | 106 | 5 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | CV-Moderate-1|CV / Virus stimulation, Condition and Cluster | 1.08e-04 | 197 | 106 | 5 | e3d00d850b4d191f9592ef993c0eaadfe5710b5f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-04 | 197 | 106 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.08e-04 | 197 | 106 | 5 | 491e12a5fca06b86443c0173f5fa750ea3b8a715 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.08e-04 | 197 | 106 | 5 | 8e655db7c6f04d49927a1f0a75178e5955b4af08 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.08e-04 | 197 | 106 | 5 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.08e-04 | 197 | 106 | 5 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 1.08e-04 | 197 | 106 | 5 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.11e-04 | 198 | 106 | 5 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.11e-04 | 198 | 106 | 5 | e2038d9239e23d670d539f1c58475fd0de028e51 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 1.11e-04 | 198 | 106 | 5 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.12e-04 | 104 | 106 | 4 | 5114600bbadb5a0d31c164afd2e8c2a7865a1423 | |
| ToppCell | control-CD163+_Monocytes_(Sample_ID1_d7)|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.14e-04 | 199 | 106 | 5 | 933201d32eda12a89660bdbae9114a95cc428a38 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 1.14e-04 | 199 | 106 | 5 | 9f6b6731186ef399f952a75879eba66fd8ed3494 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 106 | 5 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 106 | 5 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 106 | 5 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 106 | 5 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 106 | 5 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | COVID_non-vent|World / Disease condition, Lineage, Cell class and subclass | 1.16e-04 | 200 | 106 | 5 | accef1050963dc91e189ac3d38228f15bf57e06e | |
| ToppCell | Hippocampus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.76e-04 | 117 | 106 | 4 | 91936a3ffbfa29024ced9d01df962b4ccfaf8966 | |
| ToppCell | Hippocampus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.76e-04 | 117 | 106 | 4 | e33ec9044541d2ef53f6633891238559b01b7957 | |
| ToppCell | Hippocampus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.76e-04 | 117 | 106 | 4 | 454efceabe739cdf293f81c8a938811f12321a47 | |
| ToppCell | Hippocampus-Macroglia-CSF_related-EPENDYMAL|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.76e-04 | 117 | 106 | 4 | 409b3ab16786bced8c9bc9c0e89b0078402f365a | |
| Disease | centronuclear myopathy 2 (implicated_via_orthology) | 3.20e-05 | 3 | 97 | 2 | DOID:0111220 (implicated_via_orthology) | |
| Disease | muscular disease (implicated_via_orthology) | 1.06e-04 | 5 | 97 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | C1orf87 ESR2 SRC KIF16B PALB2 METTL6 FASN SULF2 CHD5 SCNN1B ANKRD30A CPSF3 | 2.10e-04 | 1074 | 97 | 12 | C0006142 |
| Disease | insulin metabolic clearance rate measurement, glucose homeostasis measurement | 9.49e-04 | 14 | 97 | 2 | EFO_0006830, EFO_0006896 | |
| Disease | Moyamoya Disease | 1.41e-03 | 17 | 97 | 2 | C0026654 | |
| Disease | mitochondrial heteroplasmy measurement | 1.54e-03 | 69 | 97 | 3 | EFO_0600008 | |
| Disease | alkaline phosphatase measurement | WIPI1 ACACB SPTBN1 KIF16B IFIT2 FARP2 SERPING1 UNC13C STK38L UTRN | 1.87e-03 | 1015 | 97 | 10 | EFO_0004533 |
| Disease | mean platelet volume | GNPDA1 NUP210L SPTBN1 KIF16B STK38 SHANK3 ACSL3 SERPING1 BIN2 STK38L | 1.94e-03 | 1020 | 97 | 10 | EFO_0004584 |
| Disease | triglyceride measurement, body fat percentage | 2.16e-03 | 21 | 97 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | Bronchiectasis | 2.37e-03 | 22 | 97 | 2 | C0006267 | |
| Disease | Coronary heart disease | 2.82e-03 | 24 | 97 | 2 | C0010068 | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 3.05e-03 | 25 | 97 | 2 | DOID:0050589 (implicated_via_orthology) | |
| Disease | age at menopause | 3.25e-03 | 302 | 97 | 5 | EFO_0004704 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MLYIKKISNIKEHLE | 271 | A0A0G2JMD5 | |
| ELIYLHAVLAMKKNK | 396 | Q7Z4L5 | |
| LEMALLYFHLKKPKI | 2656 | Q96N23 | |
| FYHVKNNGKIELIKM | 591 | P55884 | |
| SSLGDYMKNIHKKEI | 156 | Q8TF27 | |
| KLMKVHLKFEINAYD | 416 | Q9NR09 | |
| IYLIKVPAHASVKKM | 3556 | Q7Z407 | |
| VHKGNYLEMKNKFLA | 1776 | Q8TDI0 | |
| GAVQKVSKKLEMHVY | 596 | Q9UKF6 | |
| YITLLDCFHAVKKAM | 176 | O60729 | |
| QHLKSKFGKDYLLEM | 1506 | Q8IUA7 | |
| MEKAKINKYVTILHL | 121 | P12544 | |
| IAMLKLEIATLKHQY | 1111 | Q9BXX3 | |
| KNRNLYAKLLLHMLK | 61 | Q8N8E3 | |
| LSTHFMKKCNLKYIL | 96 | Q4L235 | |
| MFKHLKMTYVGLQLI | 496 | Q9HCK5 | |
| LAFHLEKVKDYLKNM | 581 | Q9P1Z9 | |
| YKDLKNFLSAVKVMH | 61 | Q9UBW5 | |
| YITLLDCFHAVKKAM | 146 | A4D256 | |
| ALMKIKHVSNFVRKY | 66 | O14578 | |
| QHIIYKMKEKRVLLS | 386 | Q8TBG4 | |
| VLNAYKSKLHKAMEI | 256 | Q9H0I3 | |
| KSKLHKAMEIYLNLD | 261 | Q9H0I3 | |
| EIMVKIIGSKHFQYL | 16 | Q8N0U7 | |
| YICMKAIKNHKPSVL | 1096 | Q6IQ32 | |
| AVLCHKLYEVMTKLG | 221 | P49418 | |
| YKALKHKTANMDVLI | 736 | Q04656 | |
| EMHKTLKLKYAELAA | 1226 | Q96L93 | |
| LLAVYHMKSAEGRKK | 221 | Q8NG85 | |
| MHYKGNKELLQLDIK | 66 | Q9Y5E4 | |
| TKYFLLKTVDQHMKL | 631 | Q2TAL8 | |
| YKLKSRGNTKMSIHL | 46 | Q9Y241 | |
| ANHKMHLYLGAAKVK | 1516 | O00763 | |
| KHLMLLRQEYVKLQK | 11 | Q9P2R3 | |
| ASQMFELIHKKLKYT | 356 | Q86T65 | |
| IHFLENAKKLSMYGV | 271 | Q9H4G0 | |
| KTMLESHKLDNIKYL | 326 | Q96AQ8 | |
| KLQHKEYLCVKAMIL | 391 | Q92731 | |
| LVDPYNILAGKHKMK | 81 | A8MVJ9 | |
| ALVMFNGKVYLLAKK | 356 | Q5T3J3 | |
| TVKYFKGLMLVHNKL | 251 | P46926 | |
| KMLEVFHAIKSVKIY | 441 | P53618 | |
| TGKSVYVKDKLMNHL | 1896 | Q6ZR08 | |
| GAHQKRLIPIKYKAM | 246 | Q99836 | |
| MHISKLKDFLIKYIS | 466 | Q9UHN1 | |
| ALEKILAVCHGVMYK | 171 | Q9UGJ1 | |
| CFLKMHLLLIAIEYK | 546 | A8MYU2 | |
| HDAGKLYAMKVLRKA | 56 | O75676 | |
| EPMLKFHYMLKKLQL | 321 | O75469 | |
| MKHILVGNKVIYKAL | 221 | Q9BXW6 | |
| NLCHYFKKLMILSTE | 1196 | Q96JM4 | |
| DKMHLVLQNIYKVLK | 166 | Q8TCB7 | |
| KTGQLLKKMHIDDSY | 1041 | Q86YC2 | |
| YLLVQLMHCRKMFKA | 506 | Q08828 | |
| MVKYLDLELHFGTQK | 861 | A4D2P6 | |
| TMLAVKFIAKYILKH | 401 | P15088 | |
| KNGDLLTMKEYHCLL | 91 | Q9H6J7 | |
| AYLTSQLHAAKKKLM | 156 | Q53HC0 | |
| VMHKEVALYLQKLKD | 136 | Q96PX6 | |
| LKLALEYIVPCMNKH | 191 | Q9GZT9 | |
| LGASVQHVKLKKMKY | 341 | Q6GMR7 | |
| LKLYHAFSAMKKVET | 151 | P05155 | |
| TVKYFKGLMHVHNKL | 251 | Q8TDQ7 | |
| ATMCNLLAYLKHLKG | 51 | P09913 | |
| SYNFIEKLKGIHIMK | 101 | Q4LDG9 | |
| YTKKQVLRMEHLVLK | 286 | P20248 | |
| CLHKLTKKGLQQRMF | 761 | O94887 | |
| KAKYHGNVMLLRAKT | 2436 | P49327 | |
| MHVKKYLLKGLHRLQ | 1 | P51168 | |
| VKCLQKTVKDSYHIM | 71 | Q96MD7 | |
| EQFKKTLSYKEHMIL | 556 | Q8NEC7 | |
| KRLNFHLYMALKKAL | 266 | Q13895 | |
| HKSAKMLLAFYEKIG | 291 | O14772 | |
| YGEIKIHVLKLNKME | 536 | Q5VU65 | |
| NLVGVVKLIMKYHSK | 326 | Q8WZA6 | |
| VYGLFMLQKKSVHKK | 321 | P41218 | |
| LLLIYSLCKHLKKMQ | 196 | P59543 | |
| LLLIYSLCKHLKKMQ | 196 | P0DTE0 | |
| IQTHLDKCMKLYKTL | 1471 | P46939 | |
| VMKKLRHEKLVQLYA | 316 | P12931 | |
| VQKKDTGHVYAMKIL | 106 | Q15208 | |
| LVQKKDTGHIYAMKI | 106 | Q9Y2H1 | |
| YRKLHMESKGNKEIL | 486 | Q6UWJ1 | |
| MSPDIALLYLKHKVK | 136 | Q7RTY7 | |
| FLKLHCLQKLYMNSV | 266 | A6NGN4 | |
| QLHMKGILKLQFSKC | 381 | P61647 | |
| TICHYFMRLLKDKGL | 146 | Q8IXJ6 | |
| ALAAAAEHKLKTMYK | 266 | Q6UW49 | |
| FLKLHCLQKLYMNSV | 266 | A3QJZ7 | |
| YAAIKTCLMHKAQLV | 1136 | Q13018 | |
| EMKVLVLSQDYGKHL | 546 | Q01082 | |
| TMKLKHTINPILLYF | 11 | O95573 | |
| KNDTVKYFKKIMLLH | 346 | Q8TCW9 | |
| MLAIGVCYHASLEKK | 2686 | Q63HN8 | |
| LKMHVFKKTLQALIY | 1076 | Q8NB66 | |
| HTKANLKKFMDYVQL | 111 | Q9BYB0 | |
| CGKSFYVLQRLKVHM | 256 | Q86VK4 | |
| QKLLFKSLSMYVCVH | 161 | Q6ZSR6 | |
| SNEKRHSYLLKLKVM | 131 | P47872 | |
| GDLTEKLKLLYKMHV | 921 | Q6ZT07 | |
| MLYIKKISNIKEHLE | 271 | O60809 | |
| ALQKLHKYMQKSLEL | 421 | Q96N46 | |
| ALKYSIPHLGKCMQK | 11 | Q4J6C6 | |
| KMFIKYIKVELLSHF | 421 | Q9UBS9 | |
| LVKVMGLSNYHCKLL | 116 | Q96JH7 | |
| KVRKMKAIYHTLNLC | 296 | Q93050 | |
| GKALMCLSLYLIHKR | 131 | Q96I27 | |
| IYIHNIKDMKLLKTL | 121 | Q5MNZ9 | |
| NLKTYHALLKMAAKC | 246 | O75127 | |
| LHVQLMELRSCKGYK | 806 | Q8IWU5 | |
| VAANKAVHLYKLGKM | 56 | Q9Y3C4 | |
| AVHLYKLGKMKTRTL | 61 | Q9Y3C4 | |
| DSGHLYAMKVLKKAT | 86 | Q15418 |